Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56


Expression pattern of the novel gene EG-1 in cancer.

Zhang L, Maul RS, Rao J, Apple S, Seligson D, Sartippour M, Rubio R, Brooks MN.

Clin Cancer Res. 2004 May 15;10(10):3504-8.


Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.

Bakkum-Gamez JN, Aletti G, Lewis KA, Keeney GL, Thomas BM, Navarro-Teulon I, Cliby WA.

Gynecol Oncol. 2008 Jan;108(1):141-8. Epub 2007 Nov 7.


Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.


The HCCR oncoprotein as a biomarker for human breast cancer.

Jung SS, Park HS, Lee IJ, Namkoong H, Shin SM, Cho GW, Ha SA, Park YG, Lee YS, Ko J, Kim JW.

Clin Cancer Res. 2005 Nov 1;11(21):7700-8.


Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.

Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL, Williams ED.

Clin Cancer Res. 2004 Aug 1;10(15):5137-44.


Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.

Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, Li M.

Clin Cancer Res. 2008 Jun 1;14(11):3319-26. doi: 10.1158/1078-0432.CCR-07-4054.


Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.

Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE, Kim JW.

Clin Cancer Res. 2004 Dec 15;10(24):8386-95.


Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.

Matusiak D, Glover S, Nathaniel R, Matkowskyj K, Yang J, Benya RV.

Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G718-28. Epub 2004 Nov 4.


Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.

Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B.

Prostate. 2007 Feb 1;67(2):203-13.


Targeted inhibition of EG-1 blocks breast tumor growth.

Lu M, Sartippour MR, Zhang L, Norris AJ, Brooks MN.

Cancer Biol Ther. 2007 Jun;6(6):936-41. Epub 2007 Mar 26.


Increased PADI4 expression in blood and tissues of patients with malignant tumors.

Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z.

BMC Cancer. 2009 Jan 30;9:40. doi: 10.1186/1471-2407-9-40.


Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis.

Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M.

Cell Biol Toxicol. 2002;18(2):87-96.


Identification of a novel prostate cancer-associated tumor antigen.

Miles AK, Rogers A, Li G, Seth R, Powe D, McArdle SE, McCulloch TA, Bishop MC, Rees RC.

Prostate. 2007 Feb 15;67(3):274-87.


Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82. Epub 2007 Nov 13.


Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.

Ma Y, Lin D, Sun W, Xiao T, Yuan J, Han N, Guo S, Feng X, Su K, Mao Y, Cheng S, Gao Y.

Clin Cancer Res. 2006 Feb 15;12(4):1121-7.


Insulin receptor expression by human prostate cancers.

Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, Vickers E, Cunningham M, Larsson O, Fazli L, Pollak M.

Prostate. 2009 Jan 1;69(1):33-40. doi: 10.1002/pros.20852.


Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.

Patrikainen L, Porvari K, Kurkela R, Hirvikoski P, Soini Y, Vihko P.

Eur J Clin Invest. 2007 Feb;37(2):126-33.


Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.

Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.

Clin Cancer Res. 2005 May 1;11(9):3184-90.


Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.

Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.

Clin Cancer Res. 2004 Oct 1;10(19):6695-702.

Supplemental Content

Support Center